KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $16.2 million.

  • Chemed's Depreciation & Amortization (CF) rose 342.1% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year increase of 252.56%. This contributed to the annual value of $63.0 million for FY2024, which is 358.83% up from last year.
  • Latest data reveals that Chemed reported Depreciation & Amortization (CF) of $16.2 million as of Q3 2025, which was up 342.1% from $16.3 million recorded in Q2 2025.
  • Chemed's Depreciation & Amortization (CF)'s 5-year high stood at $16.3 million during Q2 2025, with a 5-year trough of $14.2 million in Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $15.3 million, with a median of $15.4 million in 2023.
  • Per our database at Business Quant, Chemed's Depreciation & Amortization (CF) soared by 1396.06% in 2021 and then crashed by 550.8% in 2022.
  • Quarter analysis of 5 years shows Chemed's Depreciation & Amortization (CF) stood at $14.4 million in 2021, then grew by 1.8% to $14.6 million in 2022, then increased by 6.37% to $15.5 million in 2023, then increased by 1.88% to $15.8 million in 2024, then increased by 2.55% to $16.2 million in 2025.
  • Its last three reported values are $16.2 million in Q3 2025, $16.3 million for Q2 2025, and $16.0 million during Q1 2025.